The European Medicines Agency’s pharmacovigilance committee, PRAC, has started a review of medicines containing finasteride ...

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, ...

Sirnaomics has entered a subscription agreement with biotech specialist Poon Hung Fai, who will acquire over 17.5 million ...

GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

NHS England has proposed a phased rollout of Eli Lilly’s obesity injection Mounjaro (tirzepatide), prioritizing patients with ...

Bristol Myers Squibb has received FDA approval for Opdivo (nivolumab) combined with chemotherapy as a perioperative treatment ...

Aspire Pharma, a UK-based niche generics firm, has acquired all assets from Canute Pharma, expanding its product range and ...

Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to ...

The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC ...

F2G has raised $100 million to advance its lead antifungal drug, olorofim, despite a setback with the FDA requesting further ...

Japanese biopharma firm PeptiDream says that its wholly-owned PDRadiopharma subsidiary has entered into a strategic ...

The US FDA has granted Kite’s Yescarta (axicabtagene ciloleucel) a Regenerative Medicine Advanced Therapy (RMAT) designation ...